Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2023-504477-21-01Phase 3Completed
Phase 3, randomised, single-blind trial in well-being, Glaucoma, other ophthalmic conditions requiring gonioscopy and 1 more comparing Chloroprocaine 3% eye gel with Oxybuprocaine 0.4% eye drops (2 arms). Primary endpoint: Proportion of patients with successful conjunctival anesthesia in the right eye at 5 minutes. Started Mar 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2023-504477-21-01.